Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 9 | 2022 | 239 | 2.020 |
Why?
|
| Arrhythmias, Cardiac | 11 | 2022 | 473 | 1.760 |
Why?
|
| Sotalol | 3 | 2022 | 31 | 1.660 |
Why?
|
| Anti-Arrhythmia Agents | 12 | 2022 | 226 | 1.530 |
Why?
|
| Tachycardia, Supraventricular | 4 | 2022 | 84 | 1.210 |
Why?
|
| Heart Arrest | 5 | 2022 | 358 | 1.170 |
Why?
|
| Electrocardiography | 9 | 2019 | 1145 | 1.070 |
Why?
|
| Wolff-Parkinson-White Syndrome | 6 | 2022 | 62 | 1.010 |
Why?
|
| Heart Conduction System | 4 | 2020 | 165 | 0.990 |
Why?
|
| Ventricular Fibrillation | 2 | 2015 | 61 | 0.980 |
Why?
|
| Death, Sudden, Cardiac | 6 | 2022 | 253 | 0.960 |
Why?
|
| Flecainide | 2 | 2021 | 27 | 0.920 |
Why?
|
| Heart Rate | 5 | 2022 | 737 | 0.810 |
Why?
|
| Amiodarone | 3 | 2020 | 42 | 0.760 |
Why?
|
| Adenosine | 1 | 2022 | 289 | 0.710 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2021 | 318 | 0.690 |
Why?
|
| Heart Defects, Congenital | 7 | 2018 | 1697 | 0.600 |
Why?
|
| Heterotaxy Syndrome | 1 | 2017 | 63 | 0.600 |
Why?
|
| Pacemaker, Artificial | 4 | 2016 | 213 | 0.600 |
Why?
|
| Azithromycin | 1 | 2016 | 78 | 0.560 |
Why?
|
| Railroads | 1 | 2015 | 4 | 0.550 |
Why?
|
| Defibrillators | 1 | 2015 | 25 | 0.540 |
Why?
|
| Urban Health Services | 1 | 2015 | 37 | 0.540 |
Why?
|
| Atrioventricular Block | 1 | 2016 | 36 | 0.540 |
Why?
|
| Electric Countershock | 1 | 2015 | 71 | 0.520 |
Why?
|
| Lidocaine | 2 | 2020 | 76 | 0.510 |
Why?
|
| Community-Acquired Infections | 1 | 2016 | 285 | 0.490 |
Why?
|
| Exercise Test | 5 | 2020 | 312 | 0.490 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2015 | 89 | 0.480 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 295 | 0.470 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2016 | 300 | 0.450 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 499 | 0.430 |
Why?
|
| Child | 31 | 2022 | 29154 | 0.430 |
Why?
|
| Coronary Vessels | 1 | 2016 | 665 | 0.410 |
Why?
|
| Adolescent | 26 | 2022 | 31252 | 0.350 |
Why?
|
| Child, Preschool | 18 | 2022 | 16273 | 0.350 |
Why?
|
| Electrocardiography, Ambulatory | 2 | 2020 | 66 | 0.350 |
Why?
|
| Retrospective Studies | 28 | 2022 | 37905 | 0.340 |
Why?
|
| Infant | 15 | 2022 | 13310 | 0.340 |
Why?
|
| Catheter Ablation | 3 | 2022 | 620 | 0.330 |
Why?
|
| Atrial Fibrillation | 3 | 2022 | 719 | 0.330 |
Why?
|
| Cardiomyopathies | 5 | 2022 | 610 | 0.300 |
Why?
|
| Propranolol | 3 | 2022 | 156 | 0.290 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2022 | 24 | 0.290 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2017 | 69 | 0.270 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 14889 | 0.260 |
Why?
|
| Cardiomyopathy, Hypertrophic | 3 | 2019 | 192 | 0.260 |
Why?
|
| Cardiac Pacing, Artificial | 2 | 2020 | 127 | 0.240 |
Why?
|
| Digoxin | 2 | 2014 | 63 | 0.240 |
Why?
|
| Hospitals, Pediatric | 4 | 2017 | 773 | 0.240 |
Why?
|
| Incidence | 7 | 2020 | 5673 | 0.230 |
Why?
|
| Echocardiography | 4 | 2020 | 1182 | 0.230 |
Why?
|
| Male | 33 | 2022 | 123000 | 0.230 |
Why?
|
| Humans | 46 | 2022 | 261506 | 0.220 |
Why?
|
| Texas | 7 | 2019 | 6311 | 0.220 |
Why?
|
| Time Factors | 6 | 2022 | 12926 | 0.210 |
Why?
|
| Female | 33 | 2022 | 141928 | 0.210 |
Why?
|
| Genetic Testing | 3 | 2021 | 1589 | 0.210 |
Why?
|
| Mass Screening | 3 | 2021 | 1509 | 0.200 |
Why?
|
| Treatment Outcome | 13 | 2022 | 32848 | 0.200 |
Why?
|
| Defibrillators, Implantable | 2 | 2022 | 221 | 0.200 |
Why?
|
| Ataxia | 1 | 2022 | 176 | 0.200 |
Why?
|
| Long QT Syndrome | 2 | 2019 | 92 | 0.190 |
Why?
|
| Hospitalization | 4 | 2022 | 2083 | 0.180 |
Why?
|
| Heart Failure | 4 | 2022 | 2516 | 0.180 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 36 | 0.180 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2019 | 44 | 0.170 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 107 | 0.170 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2020 | 133 | 0.170 |
Why?
|
| Infant, Newborn | 7 | 2016 | 8223 | 0.170 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 76 | 0.170 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 305 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2020 | 9244 | 0.160 |
Why?
|
| Health Policy | 1 | 2021 | 291 | 0.160 |
Why?
|
| Survival Rate | 5 | 2020 | 12221 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 485 | 0.150 |
Why?
|
| Death, Sudden | 1 | 2017 | 59 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 249 | 0.150 |
Why?
|
| Risk Factors | 10 | 2022 | 17523 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2020 | 413 | 0.150 |
Why?
|
| Seizures | 1 | 2022 | 989 | 0.140 |
Why?
|
| Penicillins | 1 | 2016 | 143 | 0.140 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2020 | 435 | 0.140 |
Why?
|
| Cephalosporins | 1 | 2016 | 148 | 0.140 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2016 | 88 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2020 | 6869 | 0.140 |
Why?
|
| Athletes | 1 | 2016 | 73 | 0.130 |
Why?
|
| Causality | 1 | 2016 | 178 | 0.130 |
Why?
|
| Sick Sinus Syndrome | 1 | 2015 | 14 | 0.130 |
Why?
|
| Pulmonary Valve | 1 | 2016 | 87 | 0.130 |
Why?
|
| Age of Onset | 1 | 2017 | 827 | 0.130 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2015 | 36 | 0.130 |
Why?
|
| Pneumonia, Bacterial | 1 | 2016 | 130 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2016 | 69 | 0.130 |
Why?
|
| Hospital Mortality | 2 | 2022 | 1274 | 0.130 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 330 | 0.130 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 403 | 0.130 |
Why?
|
| Primary Health Care | 1 | 2021 | 787 | 0.130 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 33 | 0.130 |
Why?
|
| Postoperative Complications | 3 | 2020 | 5542 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 495 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 980 | 0.120 |
Why?
|
| Multivariate Analysis | 3 | 2016 | 4298 | 0.120 |
Why?
|
| Drug Monitoring | 2 | 2013 | 333 | 0.120 |
Why?
|
| Age Distribution | 1 | 2016 | 698 | 0.120 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 1945 | 0.120 |
Why?
|
| Fontan Procedure | 1 | 2016 | 155 | 0.120 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2016 | 244 | 0.120 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 218 | 0.110 |
Why?
|
| Ciprofloxacin | 1 | 2013 | 89 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2016 | 598 | 0.110 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 305 | 0.110 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 603 | 0.110 |
Why?
|
| Medical Audit | 1 | 2013 | 188 | 0.110 |
Why?
|
| Cardiotonic Agents | 1 | 2013 | 151 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 435 | 0.100 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 156 | 0.100 |
Why?
|
| Young Adult | 7 | 2020 | 21445 | 0.100 |
Why?
|
| Exome | 1 | 2017 | 1239 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2013 | 323 | 0.100 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2016 | 563 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 4938 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2016 | 732 | 0.090 |
Why?
|
| Surgical Wound Infection | 1 | 2013 | 450 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2016 | 2218 | 0.090 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1148 | 0.090 |
Why?
|
| Comorbidity | 1 | 2016 | 2352 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 5539 | 0.080 |
Why?
|
| Heart Atria | 2 | 2022 | 352 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2017 | 2086 | 0.080 |
Why?
|
| Guideline Adherence | 1 | 2013 | 636 | 0.080 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2007 | 10 | 0.080 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2013 | 598 | 0.080 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 2007 | 31 | 0.080 |
Why?
|
| Heart Ventricles | 3 | 2020 | 846 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 4320 | 0.070 |
Why?
|
| Echocardiography, Doppler | 1 | 2006 | 180 | 0.070 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2007 | 262 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 1171 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2016 | 9180 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2019 | 4892 | 0.060 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 1084 | 0.060 |
Why?
|
| Stroke Volume | 1 | 2006 | 577 | 0.060 |
Why?
|
| Prognosis | 3 | 2017 | 21713 | 0.060 |
Why?
|
| Heart Block | 1 | 2022 | 48 | 0.050 |
Why?
|
| Verapamil | 1 | 2022 | 78 | 0.050 |
Why?
|
| Mutation | 3 | 2020 | 15179 | 0.050 |
Why?
|
| Isoproterenol | 1 | 2022 | 127 | 0.050 |
Why?
|
| Magnesium | 1 | 2022 | 160 | 0.050 |
Why?
|
| Bereavement | 1 | 2021 | 27 | 0.050 |
Why?
|
| United States | 5 | 2017 | 15433 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 2992 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2022 | 325 | 0.050 |
Why?
|
| Physicians, Primary Care | 1 | 2021 | 98 | 0.050 |
Why?
|
| LIM Domain Proteins | 1 | 2020 | 104 | 0.050 |
Why?
|
| Ankyrins | 1 | 2020 | 104 | 0.040 |
Why?
|
| Secondary Prevention | 1 | 2021 | 329 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2021 | 255 | 0.040 |
Why?
|
| Physician's Role | 1 | 2021 | 238 | 0.040 |
Why?
|
| Adult | 7 | 2020 | 77950 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2020 | 492 | 0.040 |
Why?
|
| Calsequestrin | 1 | 2017 | 12 | 0.040 |
Why?
|
| Catecholamines | 1 | 2017 | 101 | 0.040 |
Why?
|
| Family | 1 | 2021 | 736 | 0.040 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 51 | 0.040 |
Why?
|
| Telemetry | 1 | 2016 | 39 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2022 | 787 | 0.040 |
Why?
|
| Phenotype | 2 | 2019 | 6295 | 0.040 |
Why?
|
| Recurrence | 2 | 2015 | 4758 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2016 | 355 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1890 | 0.030 |
Why?
|
| Global Health | 1 | 2020 | 657 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 244 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2020 | 1143 | 0.030 |
Why?
|
| Databases as Topic | 1 | 2014 | 133 | 0.030 |
Why?
|
| Heart Transplantation | 2 | 2015 | 908 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 974 | 0.030 |
Why?
|
| Fluoroscopy | 1 | 2015 | 232 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2017 | 1163 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2017 | 745 | 0.030 |
Why?
|
| Students | 1 | 2016 | 324 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2013 | 173 | 0.030 |
Why?
|
| Cause of Death | 1 | 2016 | 752 | 0.030 |
Why?
|
| Myocarditis | 1 | 2015 | 190 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2017 | 687 | 0.030 |
Why?
|
| Anorexia | 1 | 2013 | 143 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 1323 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 318 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 560 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2022 | 12873 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2013 | 553 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2020 | 2022 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 233 | 0.020 |
Why?
|
| Patient Safety | 1 | 2017 | 649 | 0.020 |
Why?
|
| Nausea | 1 | 2013 | 525 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2017 | 899 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 2283 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2015 | 1014 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2015 | 834 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2015 | 2316 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7573 | 0.020 |
Why?
|
| Sex Factors | 1 | 2014 | 2139 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 6009 | 0.020 |
Why?
|
| Reoperation | 1 | 2013 | 1382 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2195 | 0.020 |
Why?
|
| Logistic Models | 1 | 2015 | 3441 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 4821 | 0.020 |
Why?
|
| Diastole | 1 | 2006 | 187 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 5270 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 5377 | 0.020 |
Why?
|
| ROC Curve | 1 | 2006 | 1183 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 86204 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2006 | 6100 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 6207 | 0.010 |
Why?
|